Hip Dysplasia: Clinical Trials

2 trials for Hip Dysplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2

Follow Hip Dysplasia: new trials by email Literature Review of Hip Dysplasia trials Research Report on Hip Dysplasia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline) - Hip Dysplasia
Phase 2 / Phase 3CompletedMichael C Willey1212024-10-032026-10-07
The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy.
Dexamethasone 24mg Solution for Injection, Saline Solution for Injection - Dexamethasone, Hip Dysplasia
Phase 2 / Phase 3CompletedOdense University Hospital902020-11-122024-04-02

Narrower conditions

Hip Dislocation (2)  ·  Agnosia (1)  ·  Pain, Postoperative (1)  ·  Postoperative Nausea and Vomiting (1)

Broader conditions

Hip Injuries (2)  ·  Joint Diseases (2)  ·  Joint Dislocations (2)  ·  Musculoskeletal Diseases (2)  ·  Wounds and Injuries (2)  ·  Nausea (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)  ·  Postoperative Complications (1)  ·  Signs and Symptoms (1)

Interventions

Sodium Chloride (2)  ·  Absorptiometry, Photon (1)  ·  Dexamethasone (1)  ·  Epinephrine (1)  ·  Injections (1)  ·  Ketorolac (1)  ·  Ropivacaine (1)  ·  Saline Solution (1)  ·  Solutions (1)

Sponsors

Michael C Willey (1)  ·  Odense University Hospital (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Viktoria Lindberg-Larsen, MD, PhD (1)

Results publications

PMID 40460271

NIH funding

2019 (1)